^Melica A, Donateo L, Gerardi R, Parenti M (1991). "[A new anti-inflammatory-analgesic-antipyretic, morniflumate, in the treatment of chronic recurring bronchitis]". Rivista Europea per le Scienze Mediche e Farmacologiche = European Review for Medical and Pharmacological Sciences = Revue Européenne Pour les Sciences Médicales et Pharmacologiques. 13 (1–2): 51–60.
PMID1796197.
^Civelli M, Vigano T, Acerbi D, Caruso P, Giossi M, Bongrani S, Folco GC (July 1991). "Modulation of arachidonic acid metabolism by orally administered morniflumate in man". Agents and Actions. 33 (3–4): 233–9.
doi:
10.1007/bf01986568.
PMID1659152.
^Schiantarelli P, Cadel S, Acerbi D (February 1984). "A gastroprotective anti-inflammatory agent: the beta-morpholinoethyl ester of niflumic acid (morniflumate)". Agents and Actions. 14 (2): 247–56.
doi:
10.1007/BF01966649.
PMID6608862.